Clinical Trial Update: Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease [NA]

View source ↗

Summary

The clinical trial evaluating acamprosate for compulsive behaviors and craving in Parkinson's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Campral (acamprosate)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Parkinson's Disease | NA | Status: WITHDRAWN